I Byrjalsen Selected Research

salmon calcitonin (Calcimar)

4/2015	Treatment of symptomatic knee osteoarthritis with oral salmon calcitonin: results from two phase 3 trials.
4/2015	OA phenotypes, rather than disease stage, drive structural progression--identification of structural progressors from 2 phase III randomized clinical studies with symptomatic knee OA.
4/2011	Oral salmon calcitonin reduces cartilage and bone pathology in an osteoarthritis rat model with increased subchondral bone turnover.
4/2011	Lessons learned from the development of oral calcitonin: the first tablet formulation of a protein in phase III clinical trials.
6/2010	Biochemical markers identify influences on bone and cartilage degradation in osteoarthritis--the effect of sex, Kellgren-Lawrence (KL) score, body mass index (BMI), oral salmon calcitonin (sCT) treatment and diurnal variation.
2/2010	The effect of oral salmon calcitonin delivered with 5-CNAC on bone and cartilage degradation in osteoarthritic patients: a 14-day randomized study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

I Byrjalsen Research Topics

Disease

10	Bone Resorption 03/2013 - 09/2008
7	Osteoarthritis 01/2021 - 02/2010
6	Osteoporosis 03/2013 - 03/2008
3	Knee Osteoarthritis 01/2021 - 04/2015
3	Uterine Hemorrhage (Uterine Bleeding) 12/2007 - 03/2000
2	Atherosclerosis 01/2001 - 02/2000
1	Pain (Aches) 04/2015
1	Fibrosis (Cirrhosis) 11/2013
1	Portal Hypertension 11/2013
1	End Stage Liver Disease 11/2013
1	Osteoporotic Fractures 03/2013
1	Neoplasm Metastasis (Metastasis) 01/2011
1	Neoplasms (Cancer) 01/2011
1	Prostatic Neoplasms (Prostate Cancer) 01/2011
1	Liver Cirrhosis (Hepatic Cirrhosis) 10/2010
1	Stress Fractures (Stress Fracture) 09/2009
1	Hemorrhage 04/2007
1	Rheumatoid Arthritis 03/2007
1	Postmenopausal Osteoporosis 09/2000

Drug/Important Bio-Agent (IBA)

6	salmon calcitonin (Calcimar)FDA LinkGeneric 04/2015 - 02/2010
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 06/2010
4	CollagenIBA 01/2021 - 03/2008
4	Collagen Type I (Type I Collagen)IBA 01/2011 - 12/2008
3	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 04/2011 - 09/2008
3	Collagen Type II (Type II Collagen)IBA 06/2010 - 03/2007
2	Proteins (Proteins, Gene)FDA Link 11/2013 - 03/2000
2	TabletsIBA 03/2013 - 04/2011
2	Pharmaceutical PreparationsIBA 04/2011 - 12/2008
2	Hormones (Hormone)IBA 12/2007 - 04/2007
2	Estrogens (Estrogen)FDA Link 12/2007 - 01/2001
2	GestodeneIBA 04/2007 - 09/2000
2	Raloxifene Hydrochloride (Evista)FDA Link 01/2001 - 02/2000
2	CholesterolIBA 01/2001 - 02/2000
2	Estradiol (Delestrogen)FDA LinkGeneric 01/2001 - 09/2000
1	Extracellular Matrix ProteinsIBA 11/2013
1	Matrix Metalloproteinases (MMPs)IBA 11/2013
1	EpitopesIBA 11/2013
1	Complement C3 (C3 Complement)IBA 11/2013
1	Parathyroid Hormone (Parathormone)IBA 03/2013
1	Teriparatide (Parathar)FDA Link 03/2013
1	CreatinineIBA 04/2011
1	Peptides (Polypeptides)IBA 04/2011
1	Gonadal Steroid Hormones (Sex Hormones)IBA 04/2011
1	strontium ranelate (protelos)IBA 04/2011
1	Tartrate-Resistant Acid PhosphataseIBA 01/2011
1	Ibandronic Acid (Boniva)FDA Link 10/2010
1	OsteocalcinIBA 02/2010
1	glutamyl- lysyl- alanyl- histidyl- aspartyl- glycyl- glycyl- arginineIBA 11/2008
1	tiboloneIBA 11/2008
1	Progestins (Progestagens)IBA 12/2007
1	Levonorgestrel (Plan B)FDA LinkGeneric 04/2007
1	Selective Estrogen Receptor Modulators (SERM)IBA 01/2001
1	Progesterone Receptors (Progesterone Receptor)IBA 03/2000
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 03/2000
1	LipidsIBA 02/2000

Therapy/Procedure

6	Therapeutics 04/2011 - 09/2000
1	Injections 03/2013
1	Ligation 10/2010